Inst Diagnosti (INDISA) — Cash Flow Reinvestment Rate
Inst Diagnosti (INDISA) has a Cash Flow Reinvestment Rate of 0.21x as of June 2023, reinvesting CL$1.89 Billion (capex CL$1.74 Billion plus investments CL$144.58 Million) from operating cash flow of CL$8.87 Billion. Check INDISA operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Inst Diagnosti Cash Flow Reinvestment Rate (2014–2021)
Historical reinvestment intensity for Inst Diagnosti across 8 annual periods. Explore how much of Inst Diagnosti's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Inst Diagnosti (2014–2021)
Year-by-year capital reinvestment analysis for Inst Diagnosti. For live market cap and broader valuation context, see Inst Diagnosti stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CLP) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 4.33x | CL$64.16 Billion | CL$14.83 Billion | CL$31.45 Billion | ▲ +146.8% |
| 2020 | 1.75x | CL$25.34 Billion | CL$14.46 Billion | CL$12.45 Billion | ▲ +37.9% |
| 2019 | 1.27x | CL$13.55 Billion | CL$10.66 Billion | CL$7.44 Billion | ▲ +104.9% |
| 2018 | 0.62x | CL$9.15 Billion | CL$14.75 Billion | CL$4.72 Billion | ▼ -29.3% |
| 2017 | 0.88x | CL$13.06 Billion | CL$14.89 Billion | CL$8.63 Billion | ▼ -45.5% |
| 2016 | 1.61x | CL$18.62 Billion | CL$11.57 Billion | CL$9.73 Billion | ▲ +49.7% |
| 2015 | 1.08x | CL$16.19 Billion | CL$15.05 Billion | CL$12.30 Billion | ▲ +47.2% |
| 2014 | 0.73x | CL$9.92 Billion | CL$13.58 Billion | CL$6.03 Billion | — |